Post by i-Pharm GxP

✨ Industry update: Samsung Biologics completes its acquisition of GSK's Rockville, Maryland facility, marking its first US manufacturing presence. The move adds 60,000 liters of drug substance capacity, supporting both clinical and commercial biologics production, with plans for further investment to expand capabilities at the site. For Samsung Biologics, this is a significant move: geographic diversification, stronger regional client support, and a clear commitment to US-based biologics supply resilience.   At i-Pharm GxP, we connect specialist talent to the projects and organizations shaping the future of Life Sciences manufacturing.   👉 Want to be part of it? DM us your resume, or explore our latest opportunities here: https://lnkd.in/eqxStJwQ #Biologics #CDMO #LifeSciences #Manufacturing #SOW